（文章来源：每日经济新闻） 盛视科技（SZ 002990，收盘价：32.27元）8月21日晚间发布公告称，盛视科技股份有限公司于2025年8 月21日召开第三届董事会第三十一次会议，审议通过了《关于投资设立全资子公司的议案》。根据业务 发展和实际经营需要，公司拟使用自有资金以现金出资方式，投资设立全资子公司深圳菲菲特文化创新 有限公司，该子公司注册资本为人民币1000万元，公司持有其100%股权。 2024年1至12月份，盛视科技的营业收入构成为：软件与信息技术服务占比99.51%，其他业务占比 0.49%。 ...

Group 1: Company Performance - Sinopec reported a revenue of 1.4 trillion yuan and a net profit of 23.75 billion yuan for the first half of 2025, with a cash dividend of 0.088 yuan per share, representing a payout ratio of 49.7% [1] - GoerTek achieved a net profit of 1.42 billion yuan, marking a year-on-year increase of 15.65%, despite a revenue decline of 7.02% to 37.55 billion yuan [2] - Gree Electric announced a cash dividend of 20 yuan per 10 shares, totaling 11.17 billion yuan, based on a share base of 5.585 billion shares [3] - Jishi Media reported a revenue of 999.7 million yuan, with a net loss of 232 million yuan for the first half of 2025 [4] - Changchun High-tech's subsidiary received approval for a clinical trial of a dual-specific antibody drug, GenSci143, targeting B7-H3 and PSMA [5] - Greenme announced a strategic partnership with Weilan Lithium to develop high-energy battery materials and solid-state battery technologies [6] Group 2: Share Buybacks and Reductions - Sinopec plans to repurchase shares worth between 5 billion and 10 billion yuan through the Shanghai Stock Exchange [26] - Jiangxi Copper intends to reduce its stake in Zhongyin Securities by up to 3%, equating to 83.34 million shares [7] - Hengbang Mining plans to reduce its stake in the Hong Kong-listed company, WanGuo Gold, by up to 3.69% of its total share capital [10] Group 3: New Product Developments - Renhe Pharmaceutical's subsidiary is developing a brain-machine interaction smart glasses product, which is currently in the testing phase and has not yet generated sales revenue [11] - TianTan Bio received a commitment from its controlling shareholders to resolve new competition issues arising from a recent acquisition [12] - XianDao Intelligent has successfully developed a mass production solution for solid-state batteries and received repeat orders for related products [13] - Zejing Pharmaceutical received approval for clinical trials of ZG005 and ZGGS18 in combination with a cancer treatment drug [14] - Wantai Bio received a production approval for its nine-valent HPV vaccine, marking a new revenue stream [15]

格隆汇8月21日丨盛视科技(002990.SZ)公布，公司于2025年8月21日召开第三届董事会第三十一次会 议，审议通过了《关于投资设立全资子公司的议案》。根据业务发展和实际经营需要，公司拟使用自有 资金以现金出资方式，投资设立全资子公司深圳菲菲特文化创新有限公司(暂定名，具体以当地登记机 关核准为准)，该子公司注册资本为人民币1,000万元，公司持有其100%股权。 ...

盛视科技股份有限公司 证券代码：002990 证券简称：盛视科技 公告编号：2025-088 关于投资设立全资子公司的自愿性信息披露公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资概述 盛视科技股份有限公司（以下简称"公司"、"盛视科技"）于 2025 年 8 月 21 日召开第三届董事会第三十一次会议，审议通过了《关于投资设立全资子 公司的议案》。根据业务发展和实际经营需要，公司拟使用自有资金以现金出资 方式，投资设立全资子公司深圳菲菲特文化创新有限公司（暂定名，具体以当地 登记机关核准为准），该子公司注册资本为人民币 1,000 万元，公司持有其 100% 股权。 根据《深圳证券交易所股票上市规则》及《公司章程》等有关规定，本次投 资在董事会审议权限内，无需提交股东大会审议。董事会授权公司管理层及相关 人员办理工商核准登记有关事宜。 本次投资不构成关联交易，亦不构成《上市公司重大资产重组管理办法》规 定的重大资产重组。 二、投资标的基本情况 1.公司名称（暂定）：深圳菲菲特文化创新有限公司 2.公司类型：有限责任公司 以上信息最终以当地登 ...

证券代码：002990 证券简称：盛视科技 公告编号：2025-087 盛视科技股份有限公司 第三届董事会第三十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 盛视科技股份有限公司（以下简称"公司"）第三届董事会第三十一次会议 于 2025 年 8 月 21 日在公司会议室通过现场与通讯相结合的方式召开。本次董事 会会议通知于 2025 年 8 月 18 日以电子邮件、直接送达等方式向各位董事发出。 本次会议应出席董事 7 名（含独立董事 3 名），实际出席董事 7 名，公司监事及 高级管理人员列席了会议。会议由公司董事长瞿磊先生主持，本次会议的召集和 召开程序符合《中华人民共和国公司法》等法律法规和《公司章程》的规定，合 法有效。 二、董事会会议审议情况 审议通过《关于投资设立全资子公司的议案》 根据业务发展和实际经营需要，公司拟使用自有资金以现金出资方式，投资 设立全资子公司深圳菲菲特文化创新有限公司（暂定名，具体以当地登记机关核 准为准），该子公司注册资本为人民币 1,000 万元，公司持有其 100%股权。授 ...

盛视科技公告，公司于2025年8月21日召开第三届董事会第三十一次会议，审议通过了《关于投资设立 全资子公司的议案》。公司拟使用自有资金以现金出资方式，投资设立全资子公司深圳菲菲特文化创新 有限公司（暂定名），注册资本为人民币1000万元，公司持有其100%股权。此次投资不构成关联交 易，亦不构成《上市公司重大资产重组管理办法》规定的重大资产重组。 ...

证券日报网讯 盛视科技8月20日在互动平台回答投资者提问时表示，公司有融合激光雷达、2D/3D视觉 等多传感器的slam导航技术和BEV动态障碍实物感知技术储备，并将其运用到清洁机器人、协运机器 人、服务机器人等产品，实现机器人的自主作业和自主路径规划实时避障。 （编辑 王雪儿） ...

Core Viewpoint - The company is focusing on the promotion and innovation of its Nao robot, particularly in the education and research sectors, while also exploring new applications in other fields [1] Group 1 - The Nao robot has a high level of recognition and a solid customer base in the European and American markets [1] - The company is actively engaging with existing customers to enhance its market presence [1] - The company plans to launch the 7th generation of the Nao robot and increase marketing efforts [1]

Core Viewpoint - The company is actively working to enhance the visibility and market presence of its robotic products, particularly the Nao robot, through various promotional strategies and product launches [2]. Group 1: Company Initiatives - The company has acknowledged the low visibility of its robotic products and is planning to improve this through participation in exhibitions, new product launches, strategic partnerships, and scenario demonstrations [2]. - The Nao robot has a strong reputation and customer base in the European and American markets, and the company is focusing on connecting with existing clients [2]. - The company is committed to launching the 7th generation of the Nao robot and increasing marketing efforts to solidify its advantages in education and research while exploring innovative applications in other fields [2].

Core Viewpoint - The company is actively optimizing the products of the acquired Better Robotics and has established a new subsidiary in France to operate the core assets obtained from Aldebaran Robotics, aiming to leverage the technology and market influence of humanoid robots like Nao to create synergistic effects [2] Group 1 - The company is focusing on continuous optimization of Better Robotics' products [2] - A new subsidiary in France will be set up to operate the core assets acquired from Aldebaran Robotics [2] - The original core team of Aldebaran will be integrated to maximize the advantages of technology, brand, and market influence [2] Group 2 - The company aims to achieve a synergistic effect of "1+1>2" through the integration of resources and capabilities [2] - There are uncertainties regarding team integration, R&D progress, and market promotion effectiveness [2] - The company plans to continue enhancing its business layout through investments and acquisitions, with related matters being disclosed as necessary [2]